← Back to Screener
Gyrodyne, LLC Common Stock (GYRO)
Price$6.80
Value ScoreB
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-32.29%
Price vs S&P 500 (4W)-11.91%
VGM Score44.27
Market Capitalization$15.51M
P/E Ratio (Annual)105.05x
All Metrics
Book Value / Share (Quarterly)$15.00
P/TBV (Annual)0.47x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-3.57%
Cash Flow / Share (Quarterly)$-0.86
Price vs S&P 500 (YTD)-38.87%
Gross Margin (TTM)46.46%
Net Profit Margin (TTM)0.94%
EPS (TTM)$0.04
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$0.04
Revenue Growth (5Y)0.47%
EPS (Annual)$0.10
ROI (Annual)0.63%
Gross Margin (Annual)47.34%
Net Profit Margin (5Y Avg)572.84%
Cash / Share (Quarterly)$2.49
P/E Basic Excl Extra (TTM)301.07x
Revenue Growth QoQ (YoY)880.19%
EPS Growth (5Y)-39.03%
P/E Normalized (Annual)105.05x
ROA (Last FY)0.34%
Revenue Growth TTM (YoY)62.80%
EBITD / Share (TTM)$-0.93
ROE (5Y Avg)131.39%
Operating Margin (TTM)-46.48%
Cash Flow / Share (Annual)$-4.41
P/B Ratio0.47x
P/B Ratio (Quarterly)0.57x
Net Income / Employee (Annual)$36,900
Net Interest Coverage (TTM)-4.75x
ROA (TTM)0.11%
EPS Incl Extra (Annual)$0.10
Current Ratio (Annual)1.53x
Quick Ratio (Quarterly)0.95x
3-Month Avg Trading Volume0.00M
52-Week Price Return-0.11%
P/E Incl Extra (TTM)301.07x
Revenue / Employee (TTM)$1,366,800
Tangible BV / Share (Quarterly)$19.07
P/S Ratio (Annual)3.13x
Asset Turnover (Annual)0.11x
52-Week High$12.00
Operating Margin (5Y Avg)-95.58%
EPS Excl Extra (Annual)$0.10
CapEx CAGR (5Y)-41.13%
Tangible BV CAGR (5Y)2.66%
26-Week Price Return-16.36%
Quick Ratio (Annual)1.53x
13-Week Price Return-27.47%
Total Debt / Equity (Annual)0.37x
Current Ratio (Quarterly)0.95x
Enterprise Value$26.51M
Revenue / Share Growth (5Y)-2.29%
Asset Turnover (TTM)0.12x
Book Value / Share Growth (5Y)-8.04%
Revenue / Employee (Annual)$1,237,200
Inventory Turnover (Annual)1.04x
Pretax Margin (Annual)-74.17%
Cash / Share (Annual)$2.68
3-Month Return Std Dev35.47%
Gross Margin (5Y Avg)53.72%
Net Income / Employee (TTM)$12,900
ROE (Last FY)0.63%
Net Interest Coverage (Annual)-3.49x
EPS Basic Excl Extra (Annual)$0.10
P/FCF (TTM)0.09x
Receivables Turnover (TTM)136.68x
Total Debt / Equity (Quarterly)0.33x
EPS Incl Extra (TTM)$0.04
Receivables Turnover (Annual)95.17x
ROI (TTM)0.41%
P/S Ratio (TTM)2.84x
Pretax Margin (5Y Avg)560.16%
Revenue / Share (Annual)$3.34
Tangible BV / Share (Annual)$20.48
Price vs S&P 500 (52W)-11.77%
P/E Ratio (TTM)301.07x
EPS Growth TTM (YoY)-99.88%
Year-to-Date Return-23.70%
5-Day Price Return-7.78%
EPS Normalized (Annual)$0.10
ROA (5Y Avg)31.85%
Net Profit Margin (Annual)2.98%
Month-to-Date Return-7.24%
EBITD / Share (Annual)$-1.39
Operating Margin (Annual)-61.26%
LT Debt / Equity (Annual)0.35x
ROI (5Y Avg)130.49%
P/E Excl Extra (TTM)301.07x
LT Debt / Equity (Quarterly)0.35x
EPS Basic Excl Extra (TTM)$0.04
P/TBV (Quarterly)0.47x
P/B Ratio (Annual)0.65x
Inventory Turnover (TTM)0.82x
Pretax Margin (TTM)-59.80%
Book Value / Share (Annual)$13.91
Price vs S&P 500 (13W)-37.22%
Net Margin Growth (5Y)-37.60%
Beta0.45x
P/FCF (Annual)0.10x
Revenue / Share (TTM)$3.46
ROE (TTM)0.41%
52-Week Low$6.70
vGradeB
gGradeC
mGradeD
vgmGradeC
Show chart for
Industry Peers — Real Estate Operators — Apartments(7)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GYROGyrodyne, LLC Common Stock | B | C | D | $6.80 |
| BNBrookfield Corporation | D | C | B | $45.32 |
| PDMPiedmont Realty Trust, Inc. | C | D | B | $8.28 |
| BPYPNBrookfield Property Partners L.P. 5.750% Class A Cumulative Redeemable Perpetual Preferred Units, Series 3 | B | F | C | $13.92 |
| BPYPOBrookfield Property Partners L.P. 6.375% Class A Cumulative Redeemable Perpetual Preferred Units, Series 2 | B | F | C | $15.44 |
| MAYSMays (J.W.) Inc | D | C | B | $42.75 |
| BNHBrookfield Finance Inc. 4.625% Subordinated Notes due October 16, 2080 | — | — | C | $15.55 |
| BNJBrookfield Finance I (UK) plc 4.50% Perpetual Subordinated Notes | — | — | C | $14.93 |
About
Gyrodyne LLC is a real estate company that owns and manages industrial and medical office properties across the United States. The company generates revenue through leasing its portfolio of commercial properties, which includes the Cortlandt Manor and Flowerfield properties.